🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on the fourteenth of October at age 51 after a personal fight with pancreatic malignancy.

“The shining star of our household has faded away for us in this life,” his family stated. “After a lengthy and brave battle with cancer, we are heartbroken to announce that D’Angelo, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his pioneering modern soul style and partnerships with high-profile artists.

He released his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and received multiple award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his artistic journey into the limelight. The album premiered at the top spot on both the R&B charts and the Billboard 200. He received two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a icon, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal showed the artist, notably bare to his waist, singing straight into the camera.

D’Angelo stepped back from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a serious car crash that put him in critical condition.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the R&B chart and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public outings in the subsequent period.

The singer was announced as a headliner for the 2025 Roots Picnic festival, but his appearance was called off, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the months leading up to his death, he had reportedly been hospitalized for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose life was ended too soon.

“We are saddened that he can only leave dear memories with his loved ones, but we are eternally grateful for the heritage of extraordinarily moving music he has left us,” his kin said.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic cancer impacts the digestive organ, a tiny gland that generates insulin and plays an essential role in digestion, among other functions. The size and location of the organ in the human system make it more difficult to identify cancer.

Although this cancer accounts for only about 3% of malignancy cases annually in the United States, it is responsible for seven percent of malignancy fatalities.

Nearly 70,000 people will be diagnosed with this condition and about 52,000 will die of the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and poor prognosis. We have limited and poor treatment options, and a smaller window to make a significant difference on the lives of people,” noted a medical oncologist.

Since pancreatic cancer rarely causes early symptoms, it’s often identified only after the disease is advanced. Even when a patient has symptoms they are usually vague and may be mistaken for a several everyday ailments.

“As of yet, there is no good way to identify this malignancy in the initial phases, apart from listening to your body and speaking with your physician if there are new or unusual signs,” explained a health expert.

Frequent indicators of this disease include:

• abdominal or lower back pain
• weight loss
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s death is an outlier, as this malignancy is most common in adults in the 65 to 75 age bracket. However, many cancers, including pancreatic cancer, have become more common in younger people.

“This disease diagnosed before the age of 50 is deemed rare, yet concerningly, clinicians are beginning to see a growing number of younger patients suffering from this disease,” commented a specialist.

Family History Affects Disease Probability

In the absence of effective detection methods for pancreatic cancer, professionals emphasized the importance of knowing your family’s health background. Some risk factors, such as tobacco use and excess weight also play a role in the development of this disease.

African Americans have the greatest occurrence of this malignancy in the United States and are more prone to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s chance of pancreatic cancer is assessing individual susceptibility. Individuals should examine their family history, hereditary factors, and health issues, such as blood sugar disease, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a medical professional.

Inherited genetic risk factors are associated with as much as ten percent of all pancreatic cancer instances. If someone in your family has had this disease, you may want to consider DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, screening may involve advanced imaging such as MRI scans or internal ultrasound to find initial alterations in the organ,” he explained.

For those wishing to lower their chance, lifestyle changes may have an effect. The most effective step you can take to reduce your susceptibility of this disease is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy alcohol consumption is associated with pancreas inflammation, a risk factor for this malignancy, so limiting or abstaining from drinks may help reduce your risk.

Controlling your weight or losing weight may also aid reduce your risk. People with obesity are twenty percent more prone to develop this disease. Pancreatic cancer also occurs more often in people with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and newer combination chemotherapy. There are developing targeted therapies that already are making an impact,” remarked a expert.

For many individuals, however, awareness about this uncommon but {dev